Physicians' Prescribing Patterns for Patients with Diabetes Are Changing for the Better - 23/10/12
| Funding: None. |
|
| Conflict of Interest: Dr Rodbard conducts clinical research, serves on advisory panels, consults, and lectures with support from Amylin, BMS, Boehringer Ingelheim, Lilly, Merck, Novo Nordisk, Roche, and Sanofi. Dr Jellinger serves on advisory panels, consults, and lectures with support from Amylin, Boehringer Ingelheim, Lilly, Merck, and Novo Nordisk. |
|
| Authorship: Both authors had access to the data and a role in writing the manuscript. |
Vol 125 - N° 11
P. e11-e12 - novembre 2012 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
